clopidogrel treatment

DRUG2 trials

Sponsors

VA Office of Research and Development, University Hospital, Bordeaux

Conditions

SclerodermaSilent Brain InfarctionSystemic Sclerosis

Phase 2

Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk

RecruitingNCT05098704

University Hospital, BordeauxScleroderma, Systemic Sclerosis

Start: 2022-06-22End: 2032-06-01Target: 90Updated: 2026-07-07

Phase 4

Efficacy of Clopidogrel on Incidence of Silent Brain Infarction

Active, not recruitingNCT04698031

VA Office of Research and DevelopmentSilent Brain Infarction

Start: 2022-03-30End: 2026-12-01Updated: 2026-08-10